Fangwei Xie
- Molecular Biology
- Oncology top 10%
- Cancer Research top 10%
- Biomedical Engineering
- Electrical and Electronic Engineering
- Topics
- Cancer Cells and Metastasis (6 papers)Cancer Research and Treatments (3 papers)Cancer, Hypoxia, and Metabolism (3 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Fangwei Xie
25 papers receiving 686 citations
Peers
Comparison fields: 5 of 89
- Molecular Biology 367
- Oncology 265
- Cancer Research 165
- Biomedical Engineering 105
- Electrical and Electronic Engineering 67
Countries citing papers authored by Fangwei Xie
This map shows the geographic impact of Fangwei Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangwei Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangwei Xie more than expected).
Fields of papers citing papers by Fangwei Xie
This network shows the impact of papers produced by Fangwei Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangwei Xie. The network helps show where Fangwei Xie may publish in the future.
Co-authorship network of co-authors of Fangwei Xie
This figure shows the co-authorship network connecting the top 25 collaborators of Fangwei Xie. A scholar is included among the top collaborators of Fangwei Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fangwei Xie. Fangwei Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 25 | |
| 2 | 32 | |
| 3 | 3 | |
| 4 | 6 | |
| 5 | 87 | |
| 6 | 26 | |
| 7 | 25 | |
| 8 | 13 | |
| 9 | 9 | |
| 10 | 36 | |
| 11 | 8 | |
| 12 | 6 | |
| 13 | 23 | |
| 14 | 17 | |
| 15 | 24 | |
| 16 | 88 | |
| 17 | 88 | |
| 18 | 47 | |
| 19 | 30 | |
| 20 | Reverse effects of salidroside on expression of c-myc in SMMC-7721 cell line in vitro | 1 |
About Fangwei Xie
Fangwei Xie is a scholar working on Immunology and Allergy, Oncology and Biotechnology, having authored 26 papers that have together received 695 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (6 papers), Cancer Research and Treatments (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). The work is most often cited by research in Cancer Research (165 citations), Oncology (265 citations) and Molecular Biology (367 citations). Fangwei Xie has collaborated with scholars based in China and United States. Frequent co-authors include Xuenong Ouyang, Houjie Liang, Lee Jia, Jianfang Chen, Haiyan Dong, Kun Li, Yusheng Lu, Yu Gao, Xiaodong Xie and Keli Chen. Their work appears in journals such as Nature Communications, PLoS ONE and Advanced Functional Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.